Ovid Therapeutics (OVID) Stock Price
$1.23 1.9%
to add to portfolio
AI Score

-
Alternative
4 -
Fundamental
2 -
Technical
8
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Ovid Therapeutics, AI stock picks, stock alerts and much more.
OVID AI Stock Analysis
AI stock analysis for OVID is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Ovid Therapeutics (OVID) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Ovid Therapeutics (OVID) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Ovid Therapeutics (OVID), currently trading at $1.23, will... Sign up to access price prediction.
About OVID

-
Ovid Therapeutics Inc.
-
Symbol
OVID
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
87.2M
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$20.27 0.1% |
8 |
![]() |
Inovio Pharmaceuticals INO |
$2.46 7.3% |
3 |
![]() |
Moderna MRNA |
$23.67 6.8% |
4 |
![]() |
Anavex Life Sciences AVXL |
$9.53 0.5% |
5 |
![]() |
BridgeBio Pharma BBIO |
$51.71 1.7% |
6 |
News
OVID Alternative Data
Web Traffic
Ovid Therapeutics receives an estimated 5278 monthly visitors to ovidrx.com, which is up by 52.9% over the last month.
-
Web Traffic
5278
-
Change from Previous Month
52.9%
-
3 Month Change
24.9%
-
YoY Change
24.9%
Facebook Engagement
Ovid Therapeutics has engaged 1 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Instagram Followers
Ovid Therapeutics has 596 Instagram Followers on its main Instagram account, down by -0.3% over the last month.
-
Instagram Followers
596
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Youtube Subscribers
Ovid Therapeutics has 518 subscribers on its main Youtube channel.
-
Youtube Subscribers
518
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.2%
-
YoY Change
0.2%
LinkedIn Followers
18,088 are following Ovid Therapeutics on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
18088
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Job Postings
Ovid Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Ovid Therapeutics has 37 employees, down by -5.1% over the last month.
-
LinkedIn Employees
37
-
Daily Change
0%
-
1 Month Change
5.1%
-
3 Month Change
7.5%
-
YoY Change
7.5%
Reddit Mentions
Ovid Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Ovid Therapeutics has 1,610 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.
-
Twitter Followers
1610
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.7%
-
YoY Change
1.7%
Business Outlook
According to employee reviews, the business outlook among employees at Ovid Therapeutics is 53 out of 100 (neutral).
-
Business Outlook
53
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Ovid Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
OVID Financials
OVID Key Metrics
-
Total Revenue
$76K
-
Net Income
-$9.3M
-
Earnings per Share
-$0.13
-
Free cash flow
-$10M
-
EBITDA
-$10.6M
-
EBITDA Ratio
-138.961
-
Total Assets
$92.2M
OVID 2-year Revenue & Income
OVID 2-year Free Cash Flow
OVID Technicals
OVID SMA
OVID RSI
FAQ
What's the current price of Ovid Therapeutics (OVID) Stock?
The price of an Ovid Therapeutics (OVID) share is $1.23.
What's the market cap of Ovid Therapeutics?
The current market cap of Ovid Therapeutics is 87.2M.
What are some stocks similar to Ovid Therapeutics (OVID) that investors often compare it to?
Ovid Therapeutics (OVID) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Ovid Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Ovid Therapeutics' stock price to be around $1.26 in 2026. Starting from the current price of $1.23, this represents a 3% change in price, indicating a neutral outlook for the stock.
How to buy Ovid Therapeutics (OVID) Stock?
Ovid Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Ovid Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.